Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INTERNATIONAL STANDARDS
4.2 REGIONAL STANDARDS
4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS
4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS
4.5 FINDINGS AND REGIONAL TRENDS
4.6 COMPETITIVE GROUPING
5 COUNTRY WISE- NO OF PROCEDURES
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 REGULATION
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN THE GERIATRIC POPULATION
7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD
7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS
7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE
7.2 RESTRAINTS
7.2.1 INADEQUATE REIMBURSEMENT SCENARIO
7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
7.2.3 HIGH COST OF SURGICAL PROCEDURES
7.3 OPPORTUNITIES
7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY
8 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 MIGS STENTS
8.3 MIGS SHUNTS
8.4 OTHERS
9 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
9.1 OVERVIEW
9.2 TRABECULAR MESHWORK
9.3 SUPRACHOROIDAL SPACE
9.4 SUBCONJUNCTIVAL FILTRATION
9.5 REDUCING AQUEOUS PRODUCTION
10 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
10.1 OVERVIEW
10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
10.3 STAND-ALONE GLAUCOMA
11 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.3 OPHTHALMOLOGY CLINICS
11.4 AMBULATORY SURGERY CENTERS (ASCS)
11.5 OTHERS
12 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
13 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 ISRAEL
13.1.5 EGYPT
13.1.6 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 GLAUKOS CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.4.1 RECENT DEVELOPMENT
16.2 ALCON INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.4.1 RECENT DEVELOPMENTS
16.3 ABBVIE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.4.1 RECENT DEVELOPMENT
16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.4.1 RECENT DEVELOPMENT
16.5 SANTEN PHARMACEUTICAL CO., LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.4.1 RECENT DEVELOPMENTS
16.6 BELKIN VISION, ISRAEL
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BVI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.2.1 RECENT DEVELOPMENTS
16.8 ELLEX INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.2.1 RECENT DEVELOPMENTS
16.9 IOPTIMA
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC)
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.2.1 RECENT DEVELOPMENT
16.11 NEW WORLD MEDICAL, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.2.1 RECENT DEVELOPMENTS
16.12 NOVA EYE MEDICAL LIMITED
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.3.1 RECENT DEVELOPMENTS
16.13 SIGHT SCIENCES.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.3.1 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040
TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT
TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS
TABLE 4 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 30 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 31 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 32 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 33 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 35 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 36 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 37 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 38 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 39 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 42 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 43 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 44 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 45 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 46 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 47 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 48 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 50 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 51 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 52 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 53 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 55 REST OF MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021
FIGURE 15 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2021
FIGURE 19 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022-2029 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2022-2029)
FIGURE 21 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2021
FIGURE 23 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2022-2029)
FIGURE 25 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2021
FIGURE 27 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 31 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 33 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 35 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 36 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 37 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 38 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 39 MIDDLE EAST & AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
